Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Escalade (ESCA) Gains from Sales and Divestitures (2018 - 2025)

Escalade (ESCA) has disclosed Gains from Sales and Divestitures for 8 consecutive years, with $165485.0 as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 17.78% to $165485.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $165485.0 through Dec 2025, up 17.78% year-over-year, with the annual reading at $165485.0 for FY2025, 17.78% up from the prior year.
  • Gains from Sales and Divestitures hit $165485.0 in Q4 2025 for Escalade, up from $140502.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $165485.0 in Q4 2025 to a low of $84887.0 in Q4 2021.
  • Historically, Gains from Sales and Divestitures has averaged $119018.8 across 5 years, with a median of $107031.0 in 2023.
  • Biggest five-year swings in Gains from Sales and Divestitures: surged 51.37% in 2021 and later grew 10.13% in 2023.
  • Year by year, Gains from Sales and Divestitures stood at $84887.0 in 2021, then grew by 14.49% to $97189.0 in 2022, then increased by 10.13% to $107031.0 in 2023, then skyrocketed by 31.27% to $140502.0 in 2024, then rose by 17.78% to $165485.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for ESCA at $165485.0 in Q4 2025, $140502.0 in Q4 2024, and $107031.0 in Q4 2023.